Statistics

Total Visits

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program29

Select a period of time:

Number of views in the range

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program17

Views

Views
December 20240
January 20250
February 20253
March 202511
April 20251
May 20252
June 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
Brazil1
Spain1
Hong Kong1
 

Top cities views

Views
Hong Kong1
Piracicaba1